Please provide your email address to receive an email when new articles are posted on . Logical memory improved after kidney transplantation to a similar status as normative values. Digit symbol ...
(RTTNews) - Biopharmaceutical company Axsome Therapeutics, Inc. (AXSM) announced Monday that Sunosi met the primary endpoint in the SHARP study and significantly improved cognitive function, measured ...
NEW YORK, Oct. 03, 2022 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company developing and delivering novel therapies for the management of central nervous system ...
H. Lundbeck A/S (Lundbeck) has announced results from FOCUS, a new study(1) showing that Brintellix (vortioxetine) 10 mg and 20 mg, met its primary endpoint in demonstrating superiority versus placebo ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback